Alert Data News | Business | Companies | UK | Medical equipment & supplies

Smith & Nephew PLC

Wed, 16 May 2012 08:58:14 +0100

70 Jobs Lost - Manufacturing Transfering to China
Smith & Nephew are proposing to move the manufacturing of some products from its factory in Hull to China with the loss of up to 70 jobs by the end of next year. The company remains committed to the future of the Hull site and has created 100 additional jobs since opening its facility in China in 2009.

Corin Group PLC

Mon, 14 May 2012 09:00:03 +0100

New finance director - From June 2012
Corin Group has appointed Iain Slater as Finance Director with effect from 25 June 2012. Current Finance Director, Michael Roller, will resign from the board at that time and leave the business after a hand over. Iain will also become Company Secretary. Peter Huntley is Chief Executive Officer.

S.L.E. Limited

Fri, 11 May 2012 08:42:05 +0100

Secures Business of the Year award - recognised for manufacturing excellence
Croydon-based SLE Ltd, which manufactures neonatal ventilators, was named Business of the Year at the Croydon Business Awards 2012. SLE, which exports over 90% of its products to 80 countries worldwide was selected to receive the award because of its search for manufacturing excellence. 2011 turnover £12.6m, 77 employees.

Chromogenex Technologies Limited

Wed, 09 May 2012 08:52:39 +0100

Substantial turnover growth expected - £290,000 funding secured - 19 jobs created
Llanelli-based Chromogenex Technologies expects turnover to increase from £6.9m to £12.5m in 2012 following strong US sales of its non-surgical slimming device. It has received £290,000 from the Welsh Government Single Investment Fund and has created 19 jobs and purchased equipment to reduce manufacturing costs.

Chromogenex Plc

Fri, 04 May 2012 08:35:35 +0100

Turnover doubles - Overseas sales rise - 290,000 funding received - 19 jobs created
Cosmetic treatment company Chromogenex Technologies, based in Llanelli in Wales, has doubled its turnover to 12.5m as a result of strong sales in the US which equates for 60 per cent of the companys turnover. The company has received 290,000 funding from the Welsh government through the Single Investment Fund and repayable finance. This funding has created 19 new jobs and has enabled the company to purchase equipment to reduce manufacturing costs. Dave Morgan is Finance Director.

Elekta Ltd

Thu, 03 May 2012 08:25:15 +0100

80 new jobs - Company growth - 680 Employees
ELEKTA, a global medical technology company dedicated to oncology and neuroscience clinical advancements, has created 80 new positions at its Crawley plant to support the manufacturing of its new cancer treatment.

Surgical Innovations Group Plc

Fri, 27 Apr 2012 08:31:51 +0100

Revenue increased to £7.6m - profits up 10% £1.7m - strong sales of own-brand products
Leed-based Surgical Innovations Group, which manufactures surgical instruments, recorded revenue of £7.6m in 2011, up from £7m in 2010, while pre-tax profit increased 10% to £1.7m. Growth was helped by strong sales of own-brand products, including its Resposable brand. Further growth from new products is expected in 2012.

Smith & Nephew PLC

Wed, 25 Apr 2012 08:12:42 +0100

Transferring work from Hull to China - 40 job losses
Medical products company Smith & Nephew is transferring some manufacturing from its Advanced Wound Management facility in Hull to a new factory in Suzhou, China. 40 jobs will be lost in Hull, however new products are being developed in China and could eventually be brought to the Hull site. 2010: turnover £2.46bn, 10,172 employees.

Omega Diagnostics Group Plc

Mon, 23 Apr 2012 08:33:59 +0100

41 percent rise in sales forecast - 95 Employees
OMEGA Diagnostics is predicting sales will rise 41 percent to 11.12 million on the back of strong growth in its allergy division. The acquisition of Allergopharma's in vitro diagnostics business increased figures in that section from 1.54m to 4.47m. Kieron Harbinson is Finance Director.

Synergy Health PLC

Thu, 19 Apr 2012 08:36:59 +0100

Expects to meet earnings forecasts - positive outlook
Synergy Health, the provider of outsourced sterilisation services, has recorded trading in line with expectations in the final quarter of the year to March 2012. Earnings per share for the full year are expected to be in line with market forecasts. Year to March 2011: turnover £287.3m; 4,301 employees.